PRESS RELEASE published on 07/19/2023 at 22:00, 1 year 10 months ago ICM Controls' Soft Starter Saves Energy, Money, and Extends Motor Life
Published on 05/24/2025 at 02:00, 2 hours 4 minutes ago Battery X Metals Advances Development of Next-Generation Battery Rebalancing Technology for the #2 Out-of-Warranty Electric Vehicle in the United States
Published on 05/24/2025 at 00:00, 4 hours 4 minutes ago Forward Water Technologies Corp. Announces Change of Auditor
Published on 05/23/2025 at 23:10, 4 hours 54 minutes ago urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Published on 05/23/2025 at 22:05, 5 hours 59 minutes ago Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
Published on 05/23/2025 at 20:45, 7 hours 19 minutes ago New to The Street Launches ETF Leaders: Opportunities To Consider(TM)
Published on 05/23/2025 at 19:15, 8 hours 49 minutes ago Walls & Futures REIT PLC: Notice of General Meeting
Published on 05/23/2025 at 19:04, 9 hours ago Shareholders of Basler AG approve agenda items of today's Annual General Meeting
Published on 05/23/2025 at 18:39, 9 hours 24 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/23/2025 at 18:30, 9 hours 33 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 05/23/2025 at 17:45, 10 hours 19 minutes ago EUROPLASMA: SAO mandaté pour rechercher des partenaires financiers et industriels stratégiques
Published on 05/23/2025 at 19:00, 9 hours 4 minutes ago Paulic meunerie - notification de mise a disposition RFA 2024
Published on 05/23/2025 at 17:51, 10 hours 13 minutes ago Finalisation de la 1ère tranche du programme de rachat d'action
Published on 05/23/2025 at 17:51, 10 hours 13 minutes ago Completion of the 1st tranche of the share buyback program
Published on 05/23/2025 at 08:00, 20 hours 4 minutes ago KLARSEN : Initiation de couverture de la valeur par CHAMPEIL SA
Published on 05/23/2025 at 07:30, 20 hours 34 minutes ago Vif succès de l’augmentation de capital de NFL Biosciences avec une levée plafonnée à 3 millions d’euros
